Antibacterial immunity of lower airways: local or localized?
- 18 Downloads
Clearance of bacteria in the bronchoalveolar lavage, the level and functional activity of IgA and changes in the cellular composition of BAL were examined in mice after supralaryngeal immunization and subsequent challenge withKlebsiella pneumoniae. More than 60 % of the bacterial inoculum was removed by nonspecific mechanisms within 90 min after inoculation; within the time interval 1.5 – 3.5 h, clearance was significantly accelerated in locally immunized mice. The enhancement of clearance effectiveness is specific and increases proportionally with the length of immunization (1 < 2 < 4 weeks); it is of short duration and towards the end of the 3rd week after immunization, in 73 % of immunized animals, the clearance values did not differ from values found in controls. The local immunization did not influence the total level of IgA in BAL, the formation of specific IgA antibody was minimal,in vivo binding of IgA to klebsiella could not be demonstrated. In immunized mice, a significant increase in the numbers of PMN and lymphocytes, as well as an increased activity of phagocytic cell (PMN, MP) was found in BAL. The time interval of 1.5–3.5 h after challenge bounds the space for mechanisms, activated by local immunization in lower airways. The actual participation of individual factors in the accelerated elimination of bacteria from the lumen of airways, remains unclear so far.
KeywordsLower Airway Immunize Mouse Mucosal Immunity System Local Immune Response Clearance Effectiveness
bronchoalveolar lavage fluid
bronchus-associated lymphoid tissue
immunofluorescent, slgA secretory IgA
mucosal immunity system
Unable to display preview. Download preview PDF.
- Bienenstoc K J., Befus A.D.: Some thoughts on the biologic role of immunoglobulin A.Gastroenterology 84, 178 (1983).Google Scholar
- Challacombe S.J.: Salivary antibodies and systemic tolerance in mice after oral immunization vith bacterial antigens, inThe Secretory Immune System (J.R. McGhee, J. Mestecky, eds.).Ann. N.Y. Acad. Sci. 409, 177 (1983).Google Scholar
- Cbyz S.J. Jr.,Furer E., Germanier R.: ExperimentalKlebsiella pneumoniae burn wound sepsis: role of capsular polysaccharide.Infect. Immun. 43, 440 (1984).Google Scholar
- Fick R.B., Reynolds H.Y.: Pseudomonas respiratory infection in cystic fibrosis: a possible defect in opsonie IgG antibody?Bull. Europ. Physiopath. Resp. 19, 151 (1983).Google Scholar
- Ganguly R., Waidmas R.H.: Immunology of respiratory viruses, p. 165 inImmunology of Human Infection, Part II (A. J. Nahmias, R. J. O’Reilly, eds.). Plenum Medical Book Co., New York-London 1981.Google Scholar
- Goldstein E., Bartlema H.C.: Role of the alveolar macrophage in pulmonary bacterial defense.Bull. Europ. Physiopath. Resp. 13, 57 (1977).Google Scholar
- Hudson A.R., Kilburn K.H., Halprin G.M., McKenzie W.N.: Granulocyte recruitment to airways exposed to endotoxin aerosols.Ann. Rev. Respir. Dis. 115, 89 (1977).Google Scholar
- Kaltreider H.B.: Expression of immune mechanisms in the lung.Ann. Rev. Respir. Dis. 113, 347 (1976).Google Scholar
- La Force F.M.: Effect of aerosol immunization with RE 595Salmonella minnesota on lung bactericidal activity againstSerratia marcescens, Enterobacter cloacae, andPseudomonas aeruginosa.Am. Rev. Respir. Dis. 116, 241 (1977).Google Scholar
- La Force F.M., Boose D.S., Mills D.M.: Heightened lung bacterial activity in mice after aerosol immunization with RE 595Salmonella minnesota: importance of cellular rather than humoral factors.J. Infect. Dis. 142, 421 (1980).Google Scholar
- Lamm M.E., Rocex E., McWilliams M., Phillips-Quagliata J.M.: Lymphocyte traffic in the secretory immune system of the gut, p. 36 inThe Mucosal Immune System in Health and Disease (P. L. Ogra, J. Bienenstock, eds.). Ross Laboratories, Columbus (Ohio) 1981.Google Scholar
- Pennington J.E., Pier G.B.: Efficacy of cell wallPseudomonas aeruginosa vaccines for protection against experimental pneumonia.Rev. Infect. Dis. 5, Suppl. 5, S 852 (1983).Google Scholar
- Robbins J.H., Schneerson R.: Planning for a second (23 valent) generation of pneumococcal vaccine.Bull. Europ. Physiopath. Resp. 19, 215 (1983).Google Scholar
- Sparling P.F.: Bacterial virulence and pathogenesis: an overview.Rev. Infect. Dis. 5, Suppl. 4, S 637 (1983).Google Scholar
- Větvička V., Fornůsek L., Kopeček J., PřikrylovÁ D.: Phagocytosis of 2-hydroxyethylmethacrylate copolymer particles by different types of macrophages.Folia Biol. (Prague) 29, 424 (1983).Google Scholar